Biotech stock to buy? Fund manager diagnostics company with growth ahead
"We certainly think it's got significant growth in front of it," fund manager Dani Saurymper told Pro Talks of one diagnostics stock.
Source: cnbc.com
Stay updated with breaking news from Exact Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"We certainly think it's got significant growth in front of it," fund manager Dani Saurymper told Pro Talks of one diagnostics stock.
Both companies have outperformed the market over the past year.
Benchmark analyst Bruce D.
The ROBO Global Healthcare Technology and Innovation Index (HTEC) has underperformed compared to the equity market this year.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced separate collaborations with...